Association Between Older Age and Increasing Gleason Score

Vicini, 2005, Limitations in the use of serum prostate specific antigen levels to monitor patients after treatment for prostate cancer, J Urol, 173, 1456

Wolf, 2010, American Cancer Society guideline for the early detection of prostate cancer: update 2010, CA Cancer J Clin, 60, 70, 10.3322/caac.20066

Carter, 2013, Early detection of prostate cancer: AUA guideline, J Urol, 190, 419

Andriole, 2009, Mortality results from a randomized prostate-cancer screening trial, N Engl J Med, 360, 1310, 10.1056/NEJMoa0810696

Schröder, 2009, Screening and prostate-cancer mortality in a randomized European study, N Engl J Med, 360, 1320, 10.1056/NEJMoa0810084

Thompson, 2006, Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial, J Natl Cancer Inst, 98, 529, 10.1093/jnci/djj131

Draisma, 2006, Gleason score, age and screening: modeling dedifferentiation in prostate cancer, Int J Cancer, 119, 2366, 10.1002/ijc.22158

Surveillance, Epidemiology, and End Results (SEER) Program. SEER*Stat Database: Incidence—SEER 9 Regs Research Data, Nov 2013 Sub (1973-2011) <Katrina/Rita Population Adjustment>—Linked to County Attributes—Total US, 1969-2012 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch. Released April 2014, based on the November 2013 submission. Available at: http://www.seer.cancer.gov. Accessed November 22, 2014.

National Comprehensive Cancer Network. Clinical Practice Guidelines in Oncology, Prostate Cancer. 2015. Available at: http://www.nccn.org/professionals/physician_gls/f_guidelines.asp. Accessed November 22, 2014.

Curtin, 1998, Multiple correlations and Bonferroni's correction, Biol Psychiatry, 44, 775, 10.1016/S0006-3223(98)00043-2

Cuzick, 1985, A Wilcoxon-type test for trend, Stat Med, 4, 87, 10.1002/sim.4780040112

Epstein, 2001, Dedifferentiation of prostate cancer grade with time in men followed expectantly for stage T1c disease, J Urol, 166, 1688

Alibhai, 2004, The association between patient age and prostate cancer stage and grade at diagnosis, BJU Int, 94, 303, 10.1111/j.1464-410X.2004.04883.x

Bechis, 2011, Impact of age at diagnosis on prostate cancer treatment and survival, J Clin Oncol, 29, 235, 10.1200/JCO.2010.30.2075

Gandaglia, 2014, The effect of age at diagnosis on prostate cancer mortality: a grade-for-grade and stage-for-stage analysis, Eur J Surg Oncol, 40, 1706, 10.1016/j.ejso.2014.05.001

Borek, 1990, Relationship of age to histologic grade in prostate cancer, Prostate, 16, 305, 10.1002/pros.2990160405

Smedley, 1983, Age and survival in prostatic carcinoma, Br J Urol, 55, 529, 10.1111/j.1464-410X.1983.tb03363.x

Cher, 1995, Screening for prostate cancer, West J Med, 162, 235

Moyer, 2012, Screening for prostate cancer: US Preventive Services Task Force recommendation statement, Ann Intern Med, 157, 120, 10.7326/0003-4819-157-2-201207170-00459

Heidenreich A, Bastian PJ, Bellmunt J, et al. Guidelines on prostate cancer. Updated 2013. European Association of Urology. Available at: http://www.uroweb.org/guidelines/online-guidelines. Accessed November 22, 2014.

Heidenreich, 2013, Early detection of prostate cancer: European Association of Urology recommendation, Eur Urol, 64, 347, 10.1016/j.eururo.2013.06.051

Aslani, 2014, The impact of recent screening recommendations on prostate cancer screening in a large health care system, J Urol, 191, 1737

Ross, 2012, Impact of the 2008 US Preventive Services Task Force recommendation to discontinue prostate cancer screening among male Medicare beneficiaries, Arch Intern Med, 172, 1601, 10.1001/archinternmed.2012.3726

Penney, 2013, Gleason grade progression is uncommon, Cancer Res, 73, 5163, 10.1158/0008-5472.CAN-13-0427

Kapoor, 2013, Utilization trends and positive biopsy rates for prostate biopsies in the United States: 2005 to 2011, Rev Urol, 15, 137

Epstein, 2005, The 2005 International Society of Urological Pathology (ISUP) consensus conference on gleason grading of prostatic carcinoma, Am J Surg Pathol, 29, 1228, 10.1097/01.pas.0000173646.99337.b1

Epstein, 2010, An update of the Gleason grading system, J Urol, 183, 433

Billis, 2006, Are prostate carcinoma clinical stages T1c and T2 similar?, Int Braz J Urol, 32, 165, 10.1590/S1677-55382006000200006

Armatys, 2005, Is it necessary to separate clinical stage T1c from T2 prostate adenocarcinoma?, BJU Int, 96, 777, 10.1111/j.1464-410X.2005.05713.x